Navigation

🏠 Home 📰 Latest News 🌍 World 🇮🇳 India 💼 Business 💻 Technology ⚽ Sports 🎬 Entertainment 🏥 Health
Biggest News Aggregation in the World
📰 Us Development News

Page 57 - Us Development News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Us Development. Real-time updates on events, politics, business and more.

FDA Grants Soligenix "Fast Track" Designation for Dusquetide in the Treatment of Oral Lesions of Behçet's Disease

January 8, 2024
PRINCETON, N.J., Jan. 8, 2024 /PRNewswire/ -- Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an...
United Kingdom Robert Hancock Christopherj Schaber B Brett Finlay Biomedical Advanced Research University Of British Columbia
Source: marketscreener.com

Soligenix Announces Top-line Results of the Phase 2a Study of SGX302 (Synthetic Hypericin) in Patients with Mild-to-Moderate Psoriasis

January 4, 2024
Clinical Success Achieved in Second Cohort of Patients PRINCETON, N.J., Jan. 4, 2024 /PRNewswire/ -- Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and...
Richard Straube Christopherj Schaber Prnewswire Soligenix Inc Drug Administration World Health Organization Us Congress
Source: marketscreener.com

Soligenix Announces Publication Demonstrating Complete Protection Against Filovirus Disease in Nonhuman Primate Models of Ebola and Marburg Viruses

January 2, 2024
Single-vial thermostabilized bivalent vaccine demonstrates simultaneous protection against two lethal viruses PRINCETON, N.J., Jan. 2, 2024 /PRNewswire/ -- Soligenix, Inc. , a late-stage...
United States University Of Hawaii At Manoa Axel Lehrer Oreola Donini Prnewswire Soligenix Inc Department Of Tropical Medicine
Source: marketscreener.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

"HyBryte™ Use in Early-Stage Cutaneous T-Cell Lymphoma" Published in Frontiers in Drug Discovery

December 1, 2023
HyBryte™ has potential to address a critical gap in treatment of early-stage CTCL PRINCETON, N.J., Dec. 1, 2023 /PRNewswire/ -- Soligenix, Inc. , a late-stage biopharmaceutical company focused on...
Brian Poligone Richard Straube Prnewswire Soligenix Inc Rochester Skin Lymphoma Medical Group Us Development National Institute Of Allergy
Source: marketscreener.com

Soligenix Receives FDA IND Clearance for Phase 2 Clinical Trial of Dusquetide in the Treatment of Aphthous Ulcers in Behçet's Disease

November 30, 2023
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov. 30, 2023 /PRNewswire/ -- Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and...
United Kingdom B Brett Finlay Christopherj Schaber Robert Hancock Development Authority Exchange Commission
Source: marketscreener.com

Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting

November 17, 2023
PRINCETON, N.J., Nov. 17, 2023 /PRNewswire/ -- Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an...
Development Authority Soligenix Inc Biomedical Advanced Research Defense Threat Reduction Agency Prnewswire Soligenix Inc Our Public Health Solutions
Source: marketscreener.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science